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Introduction: The search for objective biomarkers of psychiatric disorders has a long history. Despite this,
no universally accepted instruments or methods to detect biomarkers have been developed. One po-
tential exception is near-infrared spectroscopy, although interpreting the measures of blood ﬂow re-
corded with this technique remains controversial. In this study, we aimed to investigate the relationship
between recorded blood ﬂow and depression severity assessed using the Hamilton depression scale in
patients with various psychiatric disorders.
Methods: Enrolled patients (n¼43) had DSM-IV diagnoses of major depressive disorder (n¼25), bipolar
disorder I (n¼5), schizophrenia (n¼3), dysthymic disorder (n¼3), psychotic disorder (n¼3), panic
disorder (n¼2), and Obsessive Compulsive Disorder (n¼2). The verbal ﬂuency task was administered
during blood ﬂow recording from the frontal and temporal lobes.
Results: We found that severity of depression was negatively correlated with the integral value of blood
ﬂow in the frontal lobe, irrespective of psychiatric diagnosis (F¼5.94, p¼0.02).
Discussion: Our results support blood ﬂow in the frontal lobe as a potential biomarker of depression
severity across various psychiatric disorders.
Limitation: Limited sample size, no replication in the second set.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
In 2009, near-infrared spectroscopy (NIRS) was approved by
the Ministry of Health, Labour and Welfare of Japan as an Ad-
vanced Medical Technology, for use in differential psychiatric di-
agnosis. This represented a radical change within clinical psy-
chiatry, in which diagnosis had previously been made using only
the subjective assessment of experienced clinicians. The approval
recognized a role for NIRS in distinguishing amongst people ex-
periencing depressive symptoms those with a diagnosis of schi-
zophrenia, bipolar disorder, depression or no psychiatric diagnosis.
This tool has come to the attention of patients, as well as being
reported in the popular scientiﬁc press (Cyranoski, 2011). SinceB.V. This is an open access article u
ry, Osaka Medical College, 2-
zawa).then, NIRS has been approved for use in clinical practice in over 25
institutions by the Ministry of Health, Labor and Welfare in Japan.
Furthermore, in 2013, the technology was approved for use in the
determination of healthcare insurance policies. Although many
patients appear to have beneﬁted from NIRS assessment, criticisms
remain. One major concern about using NIRS as a clinical bio-
marker was the relatively small number of patients evaluated
before the approval. Moreover, interpreting the signals derived
using NIRS is controversial, as it has been reported that skin blood
ﬂow contributes to NIRS oxyhemoglobin (oxy-Hb) concentrations
during tasks (Takahashi et al., 2011).
Other factors may further inﬂuence observations in studies
using NIRS, including severity of depression. Noda et al. (2012)
reported a highly signiﬁcant negative correlation (po0.001) be-
tween oxy-Hb and severity of depression symptoms, scaled ac-
cording to the HAMD-21 (Hamilton depression scale) (Williams,
1988; Williams et al., 2008). However, this ﬁnding was observednder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 2
Demographic data for patients with MDD (n¼25).
Variable Mean (SD)
Age 44.1 (9.3)
WAIS-IV 94.2 (20.5)
SDS 54.0 (8.9)
WHO-QOL 2.5 (0.6)
STAI/SA score 56.6 (12.0)
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(Bench et al., 1995; Kanazawa et al., 2008), during the verbal ﬂu-
ency task (VFT) (Pendleton et al., 1982).
We aimed to replicate and extend these ﬁndings by applying
NIRS in patients with diagnoses other than just major depressive
disorder (MDD). These patients were tested using the same task
but at a different institution (the National Center of Neurology and
Psychiatry in Japan) to the original report.STAI/TA score 53.5 (10.4)
SASS 29.2 (7.3)
HAMD-17 13.1 (6.5)
HAMD-21 14.4 (7.2)
BMI 25.3 (6.0)
WAIS-IV: Wechsler Adult Intelligence Scale IV; SDS: Self-rating De-
pression Scale; WHO-QOL: World Health Organization Quality of
Life; STAI-SA: State-Trait Anxiety Inventory, State Anxiety; STAO-TA:
State-Trait Anxiety Inventory, Trait Anxiety; SASS: Social Adaptation
Self-Evaluation Scale; HAMD: Hamilton Rating Scale for Depression;
BMI: Body Mass Index.2. Materials and methods
2.1. Participants
We enrolled 43 patients with a range of psychiatric diagnoses
(Table 1).
The majority of participants (n¼25) had a diagnosis of MDD
(The Diagnostic and Statistical Manual of Mental Disorders, 4th
version DSM-IV TR code: 296.20-36). Further participants with
other diagnoses were included in the analysis, including bipolar
disorder (296.40-80), dysthymic disorder (300.4), schizophrenia
(295), psychotic disorder (298.8–9), panic disorder (300.01, 21),
and OCD (Obsessive Compulsive Disorder, 300.3).
All diagnoses were assessed using the SCID-I (Structured Clinical
Interview for DSM-IV) (First et al., 2012) administered by an ex-
perienced clinician. Clinical diagnosis was based on the SCID-I as-
sessment of the current complaint, as well as the recent clinical
course. Clinical psychologists took a current and recent psychiatric
history from patients. A team comprising independent clinical psy-
chologists and psychiatrists then determined the clinical diagnosis.
Table 2 shows demographic data for all included patients with
a diagnosis of MDD. All participants were right-handed, and their
native language was Japanese. They underwent MRI scans (3 T)
and endocrine testing to detect any clinical abnormalities. All pa-
tients were recruited from the outpatient service at the Neu-
ropsychiatry Department of Osaka Medical College.
This study was carried out in accordance with the latest version
or the Declaration of Helsinki, and was approved by the ethical
committee of Osaka Medical College. Written informed consent
was obtained for all participants following an explanation of the
NIRS procedure.
2.2. Clinical assessments
Depression severity was assessed using the HAMD scale ad-
ministered by a trained psychiatrist blinded to the NIRS data.
HAMD-17 and 21 were originally designed to assess depressive
symptoms within major depression. However, there is a need for
the scale to be adapted for use in other psychiatric disorders. We
assessed the intelligence quotient (IQ) of participants using the
Wechsler Adult Intelligence Scale-III, and excluded participants
with a total score below 80.Table 1
Psychiatric diagnoses of study
participants.
Psychiatric diagnosis n
Major depressive disorder 25
Bipolar disorder I 5
Dysthymic disorder 3
Schizophrenia 3
Psychotic disorder 3
Panic disorder 2
OCD 2
Total 432.3. NIRS device
Twenty-two channel NIRS (ETG-4000; Hitachi Medical, Tokyo,
Japan) was used to derive values for oxygenated hemoglobin (oxy-
Hb) and deoxygenated hemoglobin (deoxy-Hb). We placed 18
channels over the frontal cortex and four channels over the tem-
poral cortex. The NIRS device settings were similar to those in
previous studies (Matsuo et al., 2002; Takizawa et al., 2008; Noda
et al., 2012), although we used fewer probes (22 compared with 52
channels in previous reports).
Brieﬂy, participants sat comfortably in a quiet, day-lit room.
The task procedures were explained by a clinical laboratory tech-
nician, who subsequently monitored head movement during the
procedure. To avoid the effect of motion artifacts, data with clear
evidence of head movement were omitted from further analysis.
Moreover, we employed an automatic algorithm to exclude
channels contaminated with rhythmic signals, which indicates
noise and body-movement artifacts. This algorithm recognizes
that frequencies with no signal represent no change in oxy-Hb or
deoxy-Hb concentrations at any time point. Therefore, channels in
which the standard deviation of all measurement points was zero
were deemed to be artifact channels. Further details of this algo-
rithm are reported elsewhere (Takizawa et al., 2014).2.4. Activation task
During the procedure, participants were instructed to look at a
monitor. A demonstration of the VFT procedure accompanied by
instructions from external speakers surrounding the monitor was
provided after an explanation by a clinical laboratory technician.
The task is the same as that administered in previous studies (Pu
et al., 2008; Takizawa et al., 2008).
The full task procedure included a 30 s pre-task baseline, a 60 s
VFT, and a 70 s post-task baseline. For the pre- and post-task
baseline periods, participants were instructed to repeat aloud the
ﬁve Japanese vowels ('a', 'i', 'u', 'e', 'o'). The subtraction method
(task minus pre- and post-task baseline) minimized vocalization
effects during the VFT. During the task, participants were in-
structed to generate as many Japanese words beginning with a
designated syllable as possible. The three sets of initial syllables
(1. /to/,/se/,/o/; 2. /a/,/ki/,/ha/; 3. /na/,/i/,/ta/) were presented in
counterbalanced order among the subjects, and each syllable
changed every 20 s during the 60 s task (Fig. 1).
Fig. 1. The time schedule for the cognitive activation task. The cognitive activation
task included a 30 s pre-task baseline, a 60 s VFT (3 initial syllables, one every 20 s),
and a 70 s post-task baseline.
Fig. 3. Probe positions illustrated in a 2D plane. Channels 5, 9, 14, and 18 were
positioned over the temporal lobe, whereas the rest of the channels were over the
frontal lobe.
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During the VFT task, oxy-Hb and deoxy-Hb were measured by
the following position setting of the 22 probes. The NIRS probes
were ﬁxed with 311 thermoplastic shells, with the lowest
probes positioned along the Fp1–Fp2 line, according to the inter-
national 10–20 system used in EEG. The distance between a pair of
source-detector probes was set at 3.0 cm and the area between a
pair of source-detector probes was deﬁned as a “channel”. The
probes measured Hb values from bilateral prefrontal (18 channels)
and temporal (4 channels) surface regions (Fig. 2).
The channels for which Hb values were obtained were labeled
Ch 1 to Ch 22 from right-posterior to left-anterior (Fig. 3).
We sampled data at a rate of 0.1 s. The obtained data were
analyzed using the “integral mode”: the pre-task baseline was
determined as the mean over 10 s just prior to the VFT task, and
the post-task baseline was determined as the mean over the last
5 s of the post-task period. Linear ﬁtting was applied to the data
between these two baselines. We applied a moving average
method using a window width of 5 s to remove any short-term
motion artifacts. Since a moving average method alone could not
remove all artifacts, we applied an automatic method for removing
data on individual channels with signiﬁcant artifacts, as described
above (Takizawa et al., 2008). The average measurement of oxy-Hb
and deoxy-Hb was calculated after excluding data on the channels
indicated as “bad channels” (i.e., those affected by motion artifacts)
by the automatic algorithm.Fig. 2. Anterior-superior 3D perspective of probe positions.2.6. Statistical analysis
All statistical analyses were performed using JMP Pro 11 (SAS
Institute, Japan). We calculated the Spearman's rank correlation
coefﬁcient between severity of depression and changes in oxy-Hb.
We conﬁrmed the signiﬁcance of the correlation using an ANOVA
(Analysis of Variance).
We selected oxy-Hb as the candidate biomarker of psychiatric
symptomatology because fMRI studies have found strong corre-
lations between brain activation and this measure (Yue et al.,
2013). The integral value of oxy-Hb was calculated for the tem-
poral lobe using Ch 5, 9, 14, and 18. Frontal cortex values were
calculated using the remaining channels (Ch 1–4, 6–8, 10–13, and
15–17). Data acquired on “bad channels” were excluded from the
integral value. A value of po0.05 (two-tailed) was considered to
be statistically signiﬁcant.3. Results
No obvious abnormalities requiring treatment were detected in
any participant during the brain MRI or endocrine system test.
After excluding values from “bad channels”, the obtained integral
value of the frontal lobe was inversely correlated with HAMD-21
scores (Fig. 4). An ANOVA suggested that this was a statisticallyFig. 4. Graphical bivariate ﬁt. Red solid line: linear ﬁt line for bivariate analysis;
blue dashed line: density ellipse (p¼0.95). (For interpretation of the references to
color in this ﬁgure legend, the reader is referred to the web version of this article.)
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vanished after excluding the samples any antidepressant ad-
ministered (n¼27, p¼0.227), in addition it is same in terms of lack
of the statistical signiﬁcance if the samples satisfying with MDD
criterion (n¼25, 296.20-36) is analyzed (p¼0.0642).4. Discussion
In this study, we observed a signiﬁcant negative correlation
between oxy-Hb changes in the frontal lobe and HAMD-21 scores
in patients with various psychiatric diagnoses. Our ﬁndings sup-
port the use of NIRS values as potential biomarkers for the severity
of depressive symptoms regardless of psychiatric diagnosis. Noda
et al. (2012) reported similar ﬁndings when comparing people
with depression and healthy controls. Our ﬁndings extend pre-
vious research by investigating HAMD scores of people with var-
ious psychiatric disorders, including mood and psychotic disorders
assessed using the SCID-I.
Classically, there has been a nosological distinction between
primary (psychotic or endogenous) and secondary (neurotic or
reactive) depression (Weissman et al., 1977). However, this dis-
tinction has been less useful than anticipated as more recent
psychiatric research has failed to observe any qualitative differ-
ences between episodes of primary and secondary depression
(Costello and Scott, 1991). Using only the HAMD, which was ori-
ginally designed to assess endogenous depression, for the assess-
ment of depressive symptoms may be problematic. However, it
does allow blinding of assessments by raters.
Biomarkers for psychiatric disorders are not approved if they do
not ﬁt to one speciﬁc DSM category. Inﬂuential biological re-
searchers have taken issue with this criterion for biomarker identi-
ﬁcation in psychiatry. For instance, the current director of NIMH has
written, “Imagine deciding that EKGs were not useful because many
patients with chest pain did not have EKG changes. That is what we
have been doing for decades when we reject a biomarker because it
does not detect a DSM category” (Insel, 2013). Since DSM categories
are based only on observed symptoms, biological pathogenesis is not
considered in classiﬁcation of disorders. Furthermore, individual
symptoms, which may be present in any number of psychiatric
conditions, may share underlying biological pathogenesis. Therefore,
it would be rational to suppose that depressive symptoms (assessed
using HAMD) may be represented by a single biomarker across
different psychiatric categories.
Imaging studies have indicated that individuals with depres-
sion may have an overactive amygdala and an underactive pre-
frontal cortex compared with healthy controls (Yue et al., 2013).
Depression is treated using either antidepressant medication or
cognitive behavioral therapy (CBT), or a combination of the two.
These two primary treatment strategies for depression likely tar-
get different brain regions. Antidepressant medication, such as
serotonin reuptake inhibitors (SSRIs), dampen amygdala activity,
whereas CBT acts to increase prefrontal cortex activity (Inoue et al.,
2011; Sladky et al., 2014). A limitation of the current study that
must not be ignored is the lack of information regarding received
treatment. Our ﬁnding that oxy-Hb in the frontal lobe is correlated
with depression severity could potentially be affected by a treat-
ment. Therefore, future research should consider individual
treatment in their analysis, to assess their different effects on NIRS
measures.
Several further limitations of the current study should also be
considered when interpreting our results. Previous studies have
found a correlation between depression severities and oxy-Hb at a
single channel (Ch 25), reﬂecting blood ﬂow of the dorsolateral
prefrontal cortex (Noda et al., 2012). However, in our study the
relationship was observed between depression severity and theaverage oxy-Hb across the entire frontal lobe. Nonetheless, our
ﬁnding has the potential to be reproducible across different in-
stitutions because it involves data derived from multiple channels.
Whilst analysis of individual channels is required to investigate
speciﬁc executive brain functions, such as working memory, cog-
nitive ﬂexibility or planning, reproducibility is incredibly im-
portant for biological assessments of psychological symptoms.
Further analyses using larger samples with various psychiatric
disorders could investigate the reproducibility of relationships
between speciﬁc brain areas and speciﬁc disorders.
Current psychiatric diagnosis is based on subjective clinical
assessments rather than objective biological pathology. Therefore,
the development of biomarkers for the assessment of psychiatric
symptoms has been a recent focus of research worldwide. Dis-
covery of such biomarkers could improve diagnostics and treat-
ment, as well as increasing our understanding of the etiology of
psychiatric disease. Current DSM categories are not based on un-
derlying biological pathology, and so it might be that individual
symptoms, rather than DSM deﬁned disorders, should be con-
sidered in the search for psychiatric biomarkers. Our results sup-
port this assertion, suggesting that NIRS assessment of depression
severity across various psychiatric disorders may be more in-
formative and reproducible. Future research should aim to re-
plicate these ﬁndings within larger samples, with consideration of
potential confounding factors, such as treatment.Author declarations
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